Results from Cytori Therapeutics’ (NASDAQ: CYTX) preclinical fat
grafting study have been published in the February issue of the Annals
of Plastic Surgery. This article, entitled “Supplementation of Fat
Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves
Long-Term Graft Retention,” examines the science behind cell-enriched
autologous fat grafting and its application to cosmetic and
reconstructive surgery. The results demonstrate a doubling in graft
retention in cell-enriched grafts and provide insight into the
mechanisms behind this improvement. The results reinforce both
commercial observations and interim data from the RESTORE 2 clinical
study that was presented at the San Antonio Breast Cancer Symposium in
December.
“Supplementation of Fat
Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves
Long-Term Graft Retention”
The preclinical results described in the paper support the potential
clinical utility for cell-enriched fat grafts in cosmetic and
reconstructive surgery. The key results include: